Yuchi Zhang

Dr. Yuchi Zhang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 April 2021 in Molecules
Verified
Journal Article
Open access
PDF file
YWYueqi Wang
Yueqi Wang
LGLiping Guo
Liping Guo
YZYuchi Zhang
Yuchi Zhang
YZYuchi Zhang
Yuchi Zhang
SLSainan Li
Sainan Li
Extracts of the fungus Inonotus obliquus exhibit cytotoxic properties against different cancers; hence, this fungal species has been extensively studied. This study aimed to extract total triterpenoids from Inonotus obliquus using ionic liquids (ILs) and separate potential lactate dehydrogenase (LDH) inhibitors via ultrafiltration (UF)-high-speed countercurrent chromatography (HSCCC). Total triterpenoids from Inonotus obliquus were extracted by performing a single-factor experiment and employing a central composite design via ultrasonic-assisted extraction (UAE) and heat-assisted extraction (HAE). The extract was composed of 1-butyl-3-methylimidazolium bromide as the IL and methanol as the dispersant. Ultrafiltration-liquid chromatography (UF-LC) was used to rapidly scan the LDH inhibitors and betulin and lanosterol were identified as potential inhibitors. To obtain these target compounds, betulin and lanosterol with the purities of 95.9% and 97.8% were isolated from HSCCC within 120 min. Their structures were identified using several techniques, among which IL-HAE was fast and effective. This study reports the extraction of triterpenoids from Inonotus obliquus by IL for the first time. Collectively, the findings demonstrate that UF-LC is an effective tool for screening potential LDH inhibitors from crude extracts of I. obliquus and may help to identify bioactive substances against myocardial infarction, whereas high-purity compounds can be separated via UF-HSCCC.

27 January 2023 in Molecules
Verified
Journal Article
Open access
PDF file
TWTong Wu
Tong Wu
WHWanchao Hou
Wanchao Hou
YZYuchi Zhang
Yuchi Zhang
SLSainan Li
Sainan Li
YZYuchi Zhang
Yuchi Zhang
Poria cocos (P. cocos) is a traditional Chinese medicinal product with the same origin as medicine and food. It has diuretic, anti-inflammatory and liver protection properties, and has been widely used in a Chinese medicine in the treatment of Alzheimer’s disease (AD). This study was conducted to explore the activity screening, isolation of acetylcholinesterase inhibitors (AChEIs), and in vitro inhibiting effect of P. cocos. The aim was to develop a new extraction process optimization method based on the Matlab genetic algorithm combined with a traditional orthogonal experiment. Moreover, bio−affinity ultrafiltration combined with molecular docking was used to screen and evaluate the activity of the AChEIs, which were subsequently isolated and purified using high-speed counter−current chromatography (HSCCC) and semi−preparative high-performance liquid chromatography (semi−preparative HPLC). The change in acetylcholinesterase (AChE) activity was tested using an enzymatic reaction kinetics experiment to reflect the inhibitory effect of active compounds on AChE and explore its mechanism of action. Five potential AChEIs were screened via bio−affinity ultrafiltration. Molecular docking results showed that they had good binding affinity for the active site of AChE. Meanwhile, the five active compounds had reversible inhibitory effects on AChE: Polyporenic acid C and Tumulosic acid were non-competitive inhibitors; 3−Epidehydrotumulosic acid was a mixed inhibitor; and Pachymic acid and Dehydrotrametenolic acid were competitive inhibitors. This study provided a basis for the comprehensive utilization of P. cocos and drug development for the treatment of AD.

29 December 2021 in Journal of Separation Science
Verified
Journal Article
Closed access
PDF file
SLSainan Li
Sainan Li
YLYanjie Li
Yanjie Li
YWYing Wang
Ying Wang
RLRuizhe Li
Ruizhe Li
HNHuazhou Niu
Huazhou Niu
YZYuchi Zhang
Yuchi Zhang

11 August 2022 in Journal of Chromatography B
Verified
Journal Article
Closed access
RLRuoyao Liu
Ruoyao Liu
YZYuchi Zhang
Yuchi Zhang
SLSainan Li
Sainan Li
YZYuchi Zhang
Yuchi Zhang
SZSiyuan Zhuang
Siyuan Zhuang
JLJiaqi Liang
Jiaqi Liang

20 November 2025 in Frontiers in Nutrition
Verified
Journal Article
Open access
PDF file
XLXuanlin Liu
Xuanlin Liu
YZYang Zhou
Yang Zhou
RMRui Meng
Rui Meng
JHJingyi Han
Jingyi Han
MCMing Chen
Ming Chen
YZYuchi Zhang
Yuchi Zhang
Introduction: Gardenia jasminoides root ( GJR ) is a traditional Chinese plant valued for its dual functions as both a medicinal herb and an edible resource. Alzheimer's disease (AD) is an irreversible, fatal neurodegenerative disorder in the elderly, and current treatments mainly rely on single-target acetylcholinesterase (AChE) inhibitors with limited effects on disease progression. Thus, there is an urgent need to develop dual-target inhibitors that regulate inflammation (via 5-lipoxygenase, 5-LOX) and improve cholinergic dysfunction (via AChE). Methods: To efficiently and accurately screen active compounds, receptor-ligand affinity ultrafiltration coupled with enzyme kinetics was used for rapid identification and characterization. Biochemical assays validated the inhibitory activities and mechanisms of the compounds, while molecular docking and molecular dynamics simulations evaluated target binding affinity and stability at the atomic level. An offline two-dimensional chromatographic method was developed to overcome the limitations of conventional countercurrent chromatography, enhancing peak capacity, and separation efficiency. Results: Seven active compounds were successfully isolated and identified from GJR , including Shanziside, Deacetylasperulosidic acid methyl ester, Gardoside, Shanzhiside methyl ester, Mussaenoside acid, Eleutheroside E, and 5-Hydroxy-3′,4′-dimethoxyflavone. These compounds exhibit potential dual-target inhibitory effects on 5-LOX and AChE, laying the foundation for anti-AD research. Discussion: This study integrates advanced screening, optimized extraction, and rigorous bioactivity assessment to elucidate the active components of GJR and their anti-AD potential. The developed methodology addresses the shortcomings of single-target drug development and provides valuable insights for the development of dual-target inhibitors and the advancement of plant-based food preparation technologies.